Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

SHA:600645 Revenue

Vcanbio Cell & Gene Engineering Corp., had revenue of 342.03M CNY in the quarter ending June 30, 2026, a decrease of -6.44%. This brings the company's total for the last twelve months to 1.40B, down -6.77% year-over-year. In the year 2025, Vcanbio Cell & Gene Engineering Corp., had annual revenue of 1.45B, down -8.23%. That makes Vcanbio Cell & Gene Engineering Corp., the 17,141st largest company in the world by revenue and 3,102nd in China.

• Revenue (ttm): 1.40B
• Revenue Growth: -6.77%
• P/S Ratio: 5.73
• Revenue / Employee: 722.46K
• Employees: 1,935
• Market Cap: 8.11B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacturing Industry 1.04B 71.2%
• Service Industry 419.31M 28.8%

By Geography

Chart

• China 1.12B 78.9%
• Overseas 298.90M 21.1%

Fiscal year ended Dec 31, 2025 See the full SHA:600645 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.45B	-130.47M	-8.23%
Dec 31, 2024	1.59B	-4.30M	-0.27%
Dec 31, 2023	1.59B	34.84M	2.24%
Dec 31, 2022	1.55B	19.56M	1.27%
Dec 31, 2021	1.54B	216.43M	16.41%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error